Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy

(2018) Hartmut H. Schmidt et al.   MUSCLE & NERVE

Transthyretin familial amyloid polyneuropathy: an update

(2017) Violaine Plante-Bordeneuve   JOURNAL OF NEUROLOGY

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

(2016) David Adams et al.   CURRENT OPINION IN NEUROLOGY

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe

(2016) Yesim Parman et al.   CURRENT OPINION IN NEUROLOGY

“Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy

(2016) Isabel Conceição et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Hereditary Transthyretin Amyloidosis in Eight Chinese Families

(2015) Yun Yuan et al.   CHINESE MEDICAL JOURNAL

A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK

(2015) A S Carr et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Three Turkish families with different transthyretin mutations

(2015) Can Ebru Bekircan-Kurt et al.   NEUROMUSCULAR DISORDERS

Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy

(2014) Violaine Plante-Bordeneuve   JOURNAL OF NEUROLOGY

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study

(2014) Juan Reinés et al.   Orphanet Journal of Rare Diseases

Guideline of transthyretin-related hereditary amyloidosis for clinicians

(2013) Yukio Ando et al.   Orphanet Journal of Rare Diseases

Regional differences and similarities of familial amyloidotic polyneuropathy (FAP) presentation in Brazil

(2012) Márcia Waddington Cruz   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Transthyretin Val30Met familial amyloid polyneuropathy: a considerably different clinical picture and natural course in endemic and non-endemic areas

(2012) Shu-ichi Ikeda   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy

(2012) T. Yamashita et al.   NEUROLOGY

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

(2012) C. E. Bulawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transthyretin-related familial amyloidotic polyneuropathy—Progress in Kumamoto, Japan (1967–2010)—

(2010) Shukuro ARAKI et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

(2010) David Moher et al.   International Journal of Surgery

Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population

(2008) Urban Hellman et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS